Since the discovery of chlorpromazine (CPZ) in 1952, first-generation antipsychotics (FGAs)
have revolutionized psychiatric care in terms of facilitating discharge from hospital and …

We summarized and compared meta-analyses of pharmacological and non-
pharmacological interventions targeting physical health outcomes among people with …

The American Psychiatric Association Practice Guideline for the Treatment of Patients With
Schizophrenia seeks to reduce these substantial psychosocial and public health …

Objectives Coexistence of mental and physical health conditions is prevalent. To achieve
optimal physical therapy outcomes, neither should be treated in isolation. This review aimed …

Patients with schizophrenia report reduced pain sensitivity in clinical studies, but
experimental studies are required to establish pain sensitivity as a potential endophenotype …

Objective Acquiring a diagnosis of schizophrenia reduces life expectancy for many reasons
including poverty, difficulties in communication, side‐effects of medication and access to …

The quantity and quality of evidence regarding the efficacy of physical activity for mental
illnesses is increasing. Given the established and further potential benefits and low adverse …

Several reports indicate either increased or decreased pain sensitivity associated with
psychiatric disorders. Chronic pain is highly prevalent in many of these conditions. We …

Introduction: Using an antipsychotic medication can increase prolactin (PRL) levels, causing
hyperprolactinemia (HPRL). Although the occurrence of osteoporosis within the population …

Background while many drug groups are associated with falls in older people, less is known
about absolute increases in risk and how these risks vary across different groups of drugs or …